Saccharomyces cerevisiae boulardii CNCM I-1079 affects health, growth, and fecal microbiota in milk-fed veal calves

被引:43
|
作者
Villot, C. [1 ]
Ma, T. [1 ,2 ]
Renaud, D. L. [3 ]
Ghaffari, M. H. [1 ,7 ]
Gibson, D. J. [1 ]
Skidmore, A. [4 ,5 ]
Chevaux, E. [4 ,5 ]
Guan, L. L. [1 ]
Steele, M. A. [1 ,6 ]
机构
[1] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada
[2] Chinese Acad Agr Sci, Key Lab Feed Biotechnol, Minist Agr, Feed Res Inst, Beijing 100081, Peoples R China
[3] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada
[4] Lallemand Anim Nutr, F-31702 Blagnac, France
[5] Lallemand Anim Nutr, Milwaukee, WI 53218 USA
[6] Univ Guelph, Dept Anim Biosci, Guelph, ON N1G 2W1, Canada
[7] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, D-53115 Bonn, Germany
基金
加拿大自然科学与工程研究理事会;
关键词
Saccharomyces cerevisiae boulardii; growth; fecal microbiota; diarrhea; GASTROINTESTINAL-TRACT; RISK-FACTORS; DAIRY; PERFORMANCE; MORTALITY; LACTOBACILLI; METAANALYSIS; POPULATION; MANAGEMENT; DIVERSITY;
D O I
10.3168/jds.2018-16149
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
The objective of this study was to investigate the effect of one specific strain of yeast, Saccharomyces cerevisiae boulardii CNCM I-1079 (SCB), on the growth performance, health, and fecal bacterial profile of veal calves. A total of 84 animals were enrolled in an experiment at a commercial veal farm for a total of 7 wk. Calves were fed twice a day with a milk replacer meal during the entire experiment and were randomly assigned to receive daily either SCB supplementation (10 x 10(9) cfu/d) or a placebo (CON). Individual feed intake and body weight were monitored on a daily and weekly basis, respectively. Fecal samples were collected at arrival to the veal facility (wk 0) and additional samples were taken on d 14 (wk 2) and d 49 (wk 7). These samples were subjected to 16S rRNA gene amplicon sequencing using Illumina MiSeq (Illumina Inc., San Diego, CA) to examine the bacterial profiles and real-time quantitative PCR to quantify Saccharomyces cerevisiae and specific bacterial groups. The significant increase of S. cerevisiae in the feces of SCB calves at wk 2 and 7 compared with wk 0 (respectively 1.7 x 10(7), 1.2 x 10(7), and 2.2 x 10(5) copy number of S. cerevisiae/g of feces) indicates a good survival of that yeast strain along the gastrointestinal tract. Supplementation of SCB did not improve overall growth performance with regard to average daily gain (ADG), final body weight, and feed intake. Nevertheless, a total of 69.1% of nonsupplemented calves had diarrhea and 28.6% experienced severe diarrhea, whereas 50.0% of the calves supplemented with SCB had diarrhea and 9.5% experienced severe diarrhea. With respect to antibiotic use, 89.7% of the diarrheic calves recorded in the CON group were treated, whereas only 66.7% of the SCB diarrheic calves received an antibiotic. In addition, diarrheic calves supplemented with SCB maintained an ADG similar to nondiarrheic animals, whereas the CON diarrheic calves had a significantly lower ADG in comparison with nondiarrheic CON calves. Fecalibacterium was the most predominant bacterial genus in fecal samples of nondiarrheic and diarrheic calves supplemented with SCB, whereas fecal microbiota was predominated by Collinsella in diarrheic calves from the CON group. Live yeast supplementation in milk replacer led to a decrease of diarrhea in milk-fed veal calves and the fecal microbiota of diarrheic calves maintained a healthy community similar to nondiarrheic animals, with Fecalibacterium being the predominant genus.
引用
收藏
页码:7011 / 7025
页数:15
相关论文
共 46 条
  • [31] Health and growth of veal calves fed milk replacers with or without probiotics
    Timmerman, HM
    Mulder, L
    Everts, H
    van Espen, DC
    van der Wal, E
    Klaassen, G
    Rouwers, SMG
    Hartemink, R
    Rombouts, FM
    Beynen, AC
    JOURNAL OF DAIRY SCIENCE, 2005, 88 (06) : 2154 - 2165
  • [32] Impact of health status at arrival to a milk-fed veal facility on breakeven purchase price of calves.
    Renaud, D. L.
    Dhuyvetter, K. C.
    LeBlanc, S. J.
    Kelton, D. F.
    Duffield, T. F.
    Overton, M. W.
    JOURNAL OF DAIRY SCIENCE, 2019, 102 : 112 - 112
  • [33] Effect of health status upon arrival at a single milk-fed veal facility on breakeven purchase price of calves
    Renaud, D. L.
    Dhuyvetter, K. C.
    LeBlanc, S. J.
    Kelton, D. F.
    Duffield, T. F.
    Overton, M. W.
    JOURNAL OF DAIRY SCIENCE, 2019, 102 (09) : 8441 - 8453
  • [34] Saccharomyces Cerevisiae Var Boulardii CNCM I-1079 Reduces Expression of Genes Involved in Inflammatory Response in Porcine Cells Challenged by Enterotoxigenic E. Coli and Influences Bacterial Communities in an In Vitro Model of the Weaning Piglet Colon
    Gresse, Raphaele
    Garrido, Juan J.
    Jimenez-Marin, Angeles
    Denis, Sylvain
    Van de Wiele, Tom
    Forano, Evelyne
    Blanquet-Diot, Stephanie
    Chaucheyras-Durand, Frederique
    ANTIBIOTICS-BASEL, 2021, 10 (09):
  • [35] The effect of ruminal fluid preparations on the growth and health of newborn, milk-fed dairy calves
    Muscato, TV
    Tedeschi, LO
    Russell, JB
    JOURNAL OF DAIRY SCIENCE, 2002, 85 (03) : 648 - 656
  • [36] Maternal oral supplementation with Saccharomyces boulardii I-1079 during gestation and early lactation impacts the early growth rate and metabolic profile of newborn puppies
    Bendahmane, Ilyas
    Garrigues, Quentin
    Apper, Emmanuelle
    Mugnier, Amelie
    Svilar, Ljubica
    Martin, Jean-charles
    Chastant, Sylvie
    Meynadier, Annabelle
    Mila, Hanna
    FRONTIERS IN NUTRITION, 2025, 12
  • [37] Effects of Saccharomyces cerevisiae var. boulardii on growth, incidence of diarrhea, serum immunoglobulins, and rectal microbiota of suckling dairy calves
    Lu, Qicheng
    Niu, Junli
    Wu, Yanyan
    Zhang, Wenju
    LIVESTOCK SCIENCE, 2022, 258
  • [38] Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus rhamnosus CNCM I-1720, Lactobacillus helveticus CNCM I-1722, Bifidobacterium longum subsp. longum CNCM I-3470 and Saccharomyces cerevisiae var. boulardii CNCM I-1079 and defence against pathogenic gastro-intestinal microorganisms (ID 3017, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2012, 10 (08)
  • [39] A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infants
    Xu, Lingfen
    Wang, Yun
    Wang, Yang
    Fu, Jianhua
    Sun, Mei
    Mao, Zhiqin
    Vandenplas, Yvan
    JORNAL DE PEDIATRIA, 2016, 92 (03) : 296 - 301
  • [40] Growth, survival, and metabolic activities of probiotics Lactobacillus rhamnosus GG and Saccharomyces cerevisiae var. boulardii CNCM-I745 in fermented coffee brews
    Chan, Mei Zhi Alcine
    Toh, Mingzhan
    Liu, Shao-Quan
    INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2021, 350